In addition, we further explored FAM110A expression across different cancer pathological stages using the GEPIA database and found that FAM110A mRNA expression was correlated with clinicopathological stages in BRCA, LIHC, SKCM, and THCA (Figure 2C). This evidence concerns the gene FAM110A and cancer.